ACE2 NewsLatest News On ACE2 JAK Inhibitor Tofacitinib Mitigates SARS-CoV-2 Infection Risk in Individuals with PTPN2 Genetic Variant1/17/2025 9:29 AM Study reveals key protein substitutions affect SARS-CoV-2 susceptibility in mammals11/27/2024 5:20 PM Preeclampsia and COVID-19 share pathophysiological similarities in pregnant women11/8/2024 1:30 AM New humanized mouse models created to study COVID-1910/2/2024 2:22 AM Cardiovascular risks of COVID-19 antivirals9/16/2024 4:50 AM Fibrin fuels thromboinflammation and brain damage in COVID-198/30/2024 2:52 AM Understanding the new coronavirus mutant strain KP.3.1.17/23/2024 2:57 AM High mutation count in new COVID-19 variants does not increase immune evasion, study finds7/21/2024 5:59 PM At-home antibody tests could drive higher COVID-19 booster rates, new research finds6/17/2024 8:53 AM TMPRSS2 protein facilitates SARS-CoV-2 entry via unexpected pathway6/2/2024 6:33 AM Curcuminoid compounds show promise against COVID-19 in neuronal cells5/14/2024 11:35 AM Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants5/9/2024 5:13 AM Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms4/26/2024 3:43 AM New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses4/18/2024 12:43 AM Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity4/15/2024 3:32 AM
